The Suggested Unique Association Between the Various Statin Subgroups and Prostate Cancer
European Urology Focus(2021)
摘要
Use of any statin may be associated with a lower probability of dying from prostate cancer. Hydrophilic statins (rosuvastatin and pravastatin) may also be more positively associated with a lower risk of undergoing an additional prostate biopsy and being diagnosed with prostate cancer in men aged ≥66 yr.
更多查看译文
关键词
Hydrophilic statins,Hydrophobic statins,Prostate biopsy,Prostate cancer,Prostate cancer–specific survival
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络